About this trial

Stereotactic body radiotherapy (SBRT) uses special equipment to accurately deliver a high dose of radiotherapy to the prostate in a smaller number of treatments. This study is being conducted to compare conventional radiotherapy (intensity modulated radiotherapy IMRT) over 4 weeks with SBRT over 1-2 weeks for patients with localised intermediate/high risk prostate cancer.

Patient Profile

For patients with localised intermediate/high risk prostate cancer

Where’s this trial being run?

Beacon Hospital, Bon Secours Radiotherapy Cork in Partnership with UPMC Hillman Cancer Centre, and St Luke’s Radiation Oncology Network @ Beaumont Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: PACE-C
Number: CTRIAL-IE 15-46
Full Title:

The PACE Trial (Prostate Advances in Comparative Evidence) International randomised study of prostatectomy vs stereotactic body radiotherapy (SBRT) and conventional radiotherapy vs SBRT for organ-confined prostate cancer.
PACE C: Image-Guided Conventional Radiotherapy vs Stereotactic Radiotherapy

Principal Investigator: Prof. John Armstrong (National Lead Investigator), Dr Alina Mihai (Beacon Hospital), Dr Paul Kelly (Bon Secours Radiotherapy Cork in Partnership with UPMC Hillman Cancer Centre), Dr Brian O'Neill (SLRON at Beaumont Hospital)
Type: Collaborative

Cancer Trials Ireland
Royal Marsden NHS Foundation Trust

Recruitment Started: Global:
Ireland: February 2021
Global Recruitment Target: 1182
Ireland Recruitment Target: